High-power Laser Therapy for Notalgia Paresthetica.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUşak University

About this trial

A non-invasive modality for the management of neuromusculoskeletal pain conditions that has emerged as a compelling option is high-power laser therapy (HPLT). The pathophysiology of notalgia paresthetica (NP) is treated uniquely by HPLT, which targets both the presumed muscular component of nerve entrapment and the resultant neuropathic symptoms. The main goal of this study, which is randomised, controlled and blinded by assessors, is to find out how well High-Power Laser Therapy (HPLT) works as an extra treatment to standard care in reducing itching, pain and improving quality of life for patients with long-term nerve pain.

Eligibility criteria

Qualifiers

Adults aged 18-75 years

Clinical diagnosis of unilateral Notalgia Paresthetica for at least 3 months

Presence of characteristic symptoms (pruritus, paresthesia, and/or burning pain) in the typical T2-T6 dermatomal distribution

A minimum score of 4 on the Numeric Rating Scale (NRS) for pruritus intensity

Disqualifiers

- Secondary causes of symptoms (e.g., spinal pathology, herpes zoster, renal failure)

Previous spinal surgery in the thoracic region

Coagulopathy or use of anticoagulant medication

Skin diseases or infections in the treatment area

Trial design

Treatments tested in this trial

  • High-power laser
  • Sham Laser

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Uşak University

Lead sponsor

Balikesir University

Collaborator